Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Booking signals vaccine-led travel rebound in U.S., UK as Asia lags

Published 2021-05-05, 04:13 p/m
© Reuters.

By Sanjana Shivdas

(Reuters) -Booking Holdings Inc welcomed a rebound in travel demand in the United States and Britain as more people planned holidays after getting vaccinated, but Asia remained on the back foot as its health crisis worsened.

The online travel agency's shares were marginally higher in extended trade on Wednesday, as optimism around its narrower-than-expected quarterly loss was softened by a lackluster outlook for international travel.

Booking (NASDAQ:BKNG) warned that it would take years for a full recovery in international travel, as governments may be cautious in opening borders for tourists.

"While the pace of vaccine distribution remains frustratingly slow in most places around the world, Israel, the UK and the U.S. are benefiting from successful vaccine distribution programs," said Chief Executive Officer Glenn Fogel on a post-earnings call.

"In each of these countries, we have seen encouraging booking trends, which supports our view that vaccine distribution is key to unlocking pent-up travel demand."

Booking also pointed to strong domestic room night growth in Russia and Australia. Airline tickets booked rose 49% in the first quarter versus 2019, driven by robust growth at the company's Priceline, Booking.com and Agoda brands.

While demand in Europe improved sequentially, the travel agency saw trends soften towards the end of March, driven by new travel restrictions.

In Asia, room night declines worsened in April from the prior month, hit by slow vaccination progress and government-imposed restrictions to tackle rising COVID-19 cases. Asia was the least recovered region in April.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

First-quarter gross travel bookings fell 4% to $11.9 billion from the prior year.

Excluding items, the company lost $5.26 per share, compared with analysts' estimates of a $5.87 loss per share, according to Refinitiv data.

Total revenue fell 50%, while net loss was $55 million, or $1.34 per share, in the quarter ended March 31.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.